You are using an outdated browser. Please upgrade your browser to improve your experience.

Johnson & Johnson Collaborates With Apple to Launches New Heartline App

February 25, 2020

Johnson & Johnson has just announced a new Heartline Study app to help determine if the iPhone and Apple Watch can reduce the risk of stroke for seniors 65 and older.

The company worked in collaboration with Apple to design the study which is looking to earlier detect atrial fibrillation, also known as AFib. The heart condition is the leading cause of stroke in the United States.

Anyone interested in participating in the study must be 65 or older, a U.S. resident, own an iPhone 6s or Larter, have Medicare, and agree to provide access to the Medicare claims. You can find out more about eligibility here.

In a release, Johnson & Johnson discussed some of the reasoning behind the app.

One of the key objectives of this nationwide, randomized study is to assess if a heart health engagement program provided through the Heartline Study app on iPhone, in combination with the ECG app and the irregular rhythm notification feature on Apple Watch, can reduce the likelihood of stroke and improve health outcomes with the earlier detection of AFib.

* The engagement program, via the Heartline Study app from Johnson & Johnson, will provide ongoing education, tips, surveys and questionnaires across many topics related to overall heart health throughout the two-year active engagement period.

* The ECG app can classify an electrocardiogram as sinus rhythm or AFib.

* The irregular rhythm notification feature will provide notifications of irregular heart rhythms suggestive of AFib.

You can download the app here for an iPhone. It’s free.

Download the app Now

Heartline Study
Heartline Study
Johnson & Johnson Health Technology